| HOME >> BIOLOGY >> TECHNOLOGY |
Global Biotechnology Company Licenses Pharsight's Diabetes Meta-Database to
Quantify Competitive Treatment Landscape and Accelerate Model-Based
Decision-Making
MOUNTAIN VIEW, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software and strategic services for optimizing clinical drug development, today announced that it has licensed its public-source Type II Diabetes meta-database to a global biotechnology company. The licensee plans to use the database to build quantitative models of the competitive landscape for oral diabetes treatments that will help inform clinical program decision-making for promising compounds in its diabetes pipeline. This is the first license Pharsight has sold for one of its 20 available meta-databases.
Pharsight's meta-database for Type II Non-Insulin Dependent Diabetes Mellitus (NIDDM) captures clinical efficacy and safety measures from 106 clinical trials, including multiple drug classes and comparative treatments and more than 30 clinical endpoints. Pharsight's meta-databases cover specific disease areas and have been assembled by a team of clinical database and clinical pharmacy experts dedicated to extracting information from the public domain and transforming this information into model-ready datasets.
"Clients use such a meta-database to compare the simulated efficacy and
safety of candidate drugs they are developing to the established efficacy
and safety of competing drugs," said Shawn O'Connor, president, chief
executive officer and chairman of Pharsight. "This provides an improved
understanding of the clinical potential of a drug candidate and earlier
assessment of competitive viability, which could lead to faster, more
confident decisions to invest or disinvest. Pharsight is pleased to offer
public-source clinical databases, many in high-prevalence disease areas, to
further enable efficient drug-disease mo
'/>"/>
| SOURCE Pharsight Corporation Copyright©2007 PR Newswire. All rights reserved |